Expiratory Positive Airway Pressure (EPAP) Comparison Guide
This guide compares EPAP devices on specifications including sizes, materials, warranty, payor coverage, cleaning instructions, and supporting studies.
This guide compares EPAP devices on specifications including sizes, materials, warranty, payor coverage, cleaning instructions, and supporting studies.
Tirzepatide injection becomes the first medication authorized in Canada for moderate to severe OSA, demonstrating significant reductions in breathing disruptions in clinical trials.
Research presented at ATS 2026 reveals that positional therapy conditions patients to avoid back-sleeping, maintaining obstructive sleep apnea control for up to a year after device withdrawal.
What can sleep physicians do when obstructive sleep apnea patients can't afford every recommended therapy?
The acquisition of PONM gives Nexalin ownership of the AI-integrated software supporting its HALO Clarity program, preparing for a 160-participant trial for moderate-to-severe insomnia.
The oral appliance developer aims to advance dental sleep medicine through investigator-initiated research funding and a new real-world clinical case library.
The new dual-product system aims to support the 24-hour wellness cycle, accompanied by a strategic partnership with the Calm app to offer curated sleep content.
A retrospective study explores how surgical and pharmacologic weight-loss strategies stack up in cost, effectiveness, and health outcomes.
A mastery-based cognitive-behavioral model centers on "nightmare efficacy" to help clinicians create personalized treatment plans for youth.